Microarray Market - Global Industry Analysis and Forecast, 2026-2032 | AI-Enabled Analytics and Precision Medicine Drive 9.10% CAGR Toward USD 11.79 Billion by 2032

Dublin, Oct. 19, 2026 (GLOBE NEWSWIRE) -- "Microarray Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.

This market research report examines the global microarray market, which is projected to reach USD 6.87 billion in 2026 and grow at a CAGR of 9.10% to USD 11.79 billion by 2032. It evaluates market drivers, technology shifts, artificial intelligence applications, regional trends, and competitive priorities across clinical, research, and translational genomics.

Market Overview

Microarrays remain foundational to high-throughput analysis of DNA, RNA, copy number variation, single-nucleotide polymorphisms, methylation, and protein interactions. Although next-generation sequencing adoption is expanding, microarrays retain an important role where laboratories require reproducibility, standardized interpretation, predictable costs, established workflows, and efficient processing of large sample cohorts.

Demand is supported by clinical cytogenetics, oncology, pharmacogenomics, infectious disease surveillance, agricultural genomics, and academic research. Chromosomal microarray analysis is used as a first-tier test for selected developmental disorders, congenital anomalies, and unexplained intellectual disability, while gene expression and SNP arrays support biomarker discovery, population studies, genome-wide association studies, and assay validation.

Transformative Market Shifts

Analysis of these shifts supports strategic planning by clarifying where microarrays maintain a durable advantage and where complementary sequencing capabilities may be required.

Artificial Intelligence and Advanced Analytics

Artificial intelligence is increasing microarray value by improving quality control, reducing manual interpretation, and accelerating analysis of high-dimensional datasets. Machine learning can identify expression signatures, classify copy number changes, detect outlier samples, normalize batch effects, and prioritize biomarkers.

AI-enabled analytics may also reduce turnaround times, harmonize legacy datasets, and strengthen multisite reproducibility. Clinical deployment nevertheless requires transparent validation, bias assessment, data provenance, cybersecurity safeguards, and alignment with laboratory quality standards.

Regional and Economic Group Insights

Country- and region-level comparisons enable more informed market entry decisions, partnership selection, and risk mitigation in markets with differing regulatory and infrastructure conditions.

Competitive Priorities and Recommended Actions

These competitive insights help organizations identify differentiated opportunities and align product development with the practical requirements of clinical and research laboratories.

Key Takeaways from This Report

Key Attributes:

Key Topics Covered:

1. Preface

1.1. Objectives of the Study

1.2. Market Definition

1.3. Market Segmentation & Coverage

1.4. Years Considered for the Study

1.5. Currency Considered for the Study

1.6. Language Considered for the Study

1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction

2.2. Research Design

2.2.1. Primary Research

2.2.2. Secondary Research

2.3. Research Framework

2.3.1. Qualitative Analysis

2.3.2. Quantitative Analysis

2.4. Market Size Estimation

2.4.1. Top-Down Approach

2.4.2. Bottom-Up Approach

2.5. Data Triangulation

2.6. Research Outcomes

2.7. Research Assumptions

2.8. Research Limitations

3. Executive Summary

3.1. Introduction

3.2. CXO Perspective

3.3. New Revenue Opportunities

3.4. Next-Generation Business Models

3.5. Industry Roadmap

4. Market Overview

4.1. Introduction

4.2. Industry Ecosystem & Value Chain Analysis

4.2.1. Supply-Side Analysis

4.2.2. Demand-Side Analysis

4.2.3. Stakeholder Analysis

4.3. Market Dynamics

4.3.1. Key Drivers

4.3.2. Key Restraints

4.3.3. Key Opportunities

4.3.4. Key Challenges

4.4. Porter's Five Forces Analysis

4.5. PESTLE Analysis

4.6. Market Outlook

4.6.1. Near-Term Market Outlook (0-2 Years)

4.6.2. Medium-Term Market Outlook (3-5 Years)

4.6.3. Long-Term Market Outlook (5-10 Years)

4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective

5.2. Consumer Experience Benchmarking

5.3. Opportunity Mapping

5.4. Distribution Channel Analysis

5.5. Pricing Trend Analysis

5.6. Regulatory Compliance & Standards Framework

5.7. ESG & Sustainability Analysis

5.8. Disruption & Risk Scenarios

5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Microarray Market, by Product Type

7.1. Introduction

7.2. DNA Microarrays

7.3. Protein Microarrays

7.4. Tissue Microarrays

7.5. Carbohydrate / Glycan Microarrays

7.6. Antibody Microarrays

8. Microarray Market, by Technology Type

8.1. Introduction

8.2. DNA Spotting / Glass Slide Microarrays

8.3. Affymetrix-style In Situ Synthesized Arrays

8.4. Bead-based Microarrays

8.5. Microfluidic Microarrays

9. Microarray Market, by Sample Type

9.1. Introduction

9.2. Blood

9.3. Tissue Biopsies

9.4. Buccal Swabs

9.5. Saliva

10. Microarray Market, by Application

10.1. Introduction

10.2. Diagnostics

10.3. Drug Discovery

10.4. Genomics

10.5. Personalized Medicine

11. Microarray Market, by End User

11.1. Introduction

11.2. Academic & Research Institutes

11.3. Contract Research Organizations

11.4. Hospitals & Diagnostic Centers

11.5. Pharmaceutical & Biotechnology

12. Microarray Market, by Region

12.1. Introduction

12.2. Asia-Pacific

12.3. North America

12.4. Latin America

12.5. Europe

12.6. Middle East

12.7. Africa

13. Microarray Market, by Group

13.1. Introduction

13.2. ASEAN

13.3. GCC

13.4. European Union

13.5. BRICS

13.6. G7

13.7. NATO

14. Microarray Market, by Country

14.1. Introduction

14.2. United States

14.3. Canada

14.4. Mexico

14.5. Brazil

14.6. United Kingdom

14.7. Germany

14.8. France

14.9. Russia

14.10. Italy

14.11. Spain

14.12. China

14.13. India

14.14. Japan

14.15. Australia

14.16. South Korea

15. Competitive Landscape

15.1. Market Share Analysis, 2025

15.2. Market Concentration Analysis, 2025

15.2.1. Concentration Ratio (CR)

15.2.2. Herfindahl Hirschman Index (HHI)

15.3. Recent Developments & Impact Analysis, 2025

15.4. Product Portfolio Analysis, 2025

15.5. Benchmarking Analysis, 2025

16. Company Profiles

16.1. Agilent Technologies, Inc.

16.2. Akonni Biosystems, Inc.

16.3. Applied Micro Arrays, Inc.

16.4. Arrayit Corporation

16.5. Arrayjet Ltd.

16.6. Bio-Rad Laboratories, Inc.

16.7. bioMerieux SA

16.8. CapitalBio Technology Co., Ltd.

16.9. CD Genomics, Inc.

16.10. Creative Biolabs, Inc.

16.11. Danaher Corporation

16.12. F. Hoffmann-La Roche AG

16.13. GE HealthCare Technologies Inc.

16.14. Illumina, Inc.

16.15. JPT Peptide Technologies GmbH

16.16. Macrogen, Inc.

16.17. Merck KGaA

16.18. Microarrays Inc.

16.19. OncoMark Limited

16.20. Oxford Gene Technology IP Limited

16.21. PamGene International BV

16.22. PerkinElmer, Inc.

16.23. QIAGEN N.V.

16.24. RayBiotech, Inc.

16.25. Revvity, Inc.

16.26. Sciomics GmbH

16.27. Thermo Fisher Scientific Inc.

16.28. Z Biotech, LLC

17. Key Experts

List of Figures [21]

List of Tables [237]

For more information about this report visit https://www.researchandmarkets.com/r/derybs

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.